Etude de la drépanocytose chez l’enfant au Centre Hospitalier Régional de Kenitra (Maroc): Impact sur le profil de la santé

Cite this:
[1]
K. H. H. B. Y. E. M. Y. E. G. Omar AMAHMID, My Mustapha HAFID,Hajar DA, “Etude de la drépanocytose chez l’enfant au Centre Hospitalier Régional de Kenitra (Maroc): Impact sur le profil de la santé”, ijmhs, vol. 8, no. 10, pp. 186–193, Oct. 2018.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
410
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF  

Abstract

Sickle cell syndromes pose real public health problems in many African countries also described in the populations of the Mediterranean basin. In Morocco, their frequency and their distribution are poorly known. The objectives of this study are; first, to highlight the epidemiological characteristics second, plot the current mapping of the disease in children under 15 years old of age. A retrospective study was carried out on 86 patients from 01 January to 31 December 2015 at the pediatric department at El Idrissi Regional Hospital Center in Kenitra. The mean age of patient was 7.8 ± 3.1 years; the male sex was the most dominant with 55.81% of patients studied. The SS form represented the majority of cases with 79.07%. Sickle cell anemia remains a reality in our country and not perfectly understood yet by health professionals. A screening policy and a sustainable management program can prevent hemoglobinopathies in our region. An action plan must be implemented at national level to improve the quality of management of main sickle cell syndromes.

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”